- Report
- October 2025
- 190 Pages
Global
From €3157EUR$3,545USD£2,748GBP
€3507EUR$3,939USD£3,053GBP
- Report
- October 2025
- 372 Pages
Global
From €5209EUR$5,850USD£4,535GBP
Microalbuminuria is a medical condition in which small amounts of albumin, a type of protein, are found in the urine. It is a marker of kidney damage and is commonly seen in patients with urological and nephrological conditions such as diabetes, hypertension, and glomerulonephritis. It is usually detected through a urine test, and can be used to diagnose and monitor kidney disease. Treatment typically involves lifestyle changes such as diet and exercise, as well as medications to control blood pressure and blood sugar levels.
The microalbuminuria market is an important part of the urology and nephrology industry, as it provides a way to diagnose and monitor kidney disease. It is a growing market, with a range of products and services available to help diagnose and treat the condition. Companies in this market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Alere. Show Less Read more